Medicines and Healthcare products Regulatory Agency
WHOLESALE DISTRIBUTION AUTHORISATION
(MEDICINAL PRODUCTS FOR HUMAN USE)
1. Authorisation Number | UK WDA(H) 15694 |
2. Name of Authorisation Holder | ALLOGA UK LIMITED |
3. Legally registered address of Authorisation Holder | ALLOGA UK LIMITED, AMBER PARK 1, 2, AND 3, BERRISTOW LANE, SOUTH NORMANTON, ALFRETON, DE55 2FH, UNITED KINGDOM |
4. Address(es) of Site(s) |
ALLOGA UK LTD, AMBER PARK 9, UNIT 1, FARMWELL LANE, SUTTON-IN-ASHFIELD, NG17 1BX, UNITED KINGDOM ALLOGA UK LIMITED, AMBER PARK 1, 2, AND 3, BERRISTOW LANE, SOUTH NORMANTON, ALFRETON, DE55 2FH, UNITED KINGDOM ALLOGA UK LIMITED, AMBER PARK 7A, UNIT CW72, FARMWELL LANE, SUTTON-IN-ASHFIELD, NG17 1BX, UNITED KINGDOM ALLOGA UK LIMITED, AMBER PARK 5 AND 6, UNIT C2, FARMWELL LANE, SOUTH NORMANTON, ALFRETON, DE55 2JX, UNITED KINGDOM ALLOGA UK LIMITED, UNIT 5, FARMWELL LANE, SUTTON-IN-ASHFIELD, NG17 1BX, UNITED KINGDOM ALLOGA UK LIMITED, AMBER PARK 8, DERBY 370, DERBY COMMERCIAL PARK, RAYNESWAY, DERBY, DE21 7HW, UNITED KINGDOM |
5. Scope of authorisation (complete for each site under 4) | ANNEX 1 |
6. Legal basis of authorisation | Regulation 18 of the Human Medicines Regulations 2012 |
7. Name of responsible officer of the competent authority of the member state granting the wholesaling authorisation | Confidential |
8. Date | 09/07/2024 |
9. Annexes attached | Annex 1 Scope of wholesale distribution authorisation
Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number
Annex 3 (Optional) Name(s) of responsible person(s)
Annex 4 (Optional) Date of Inspection on which authorisation was granted
Annex 5 Additional provisions |
ALLOGA UK LTD, AMBER PARK 9, UNIT 1, FARMWELL LANE, SUTTON-IN-ASHFIELD, NG17 1BX, UNITED KINGDOM
1. MEDICINAL PRODUCTS |
1.1 With “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) |
1.2 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in GB or EEA and intended for the UK market |
1.3 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in the UK and not intended for the UK market |
2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS |
2.1 Procurement |
2.2 Holding |
2.3 Supply |
2.4 Export |
2.6 Products imported from countries on a list |
2.6a Products certified under Article 51 of Directive 2001/83/EC |
2.6b Products not certified under Article 51 of Directive 2001/83/EC |
3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS |
3.1.1 Narcotic or psychotropic products |
3.1.2 Medicinal products derived from blood |
3.1.3 Immunological medicinal products |
3.1.4 Radiopharmaceutical (including radionuclide kits) |
3.1.5 Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc) |
ALLOGA UK LIMITED, AMBER PARK 1, 2, AND 3, BERRISTOW LANE, SOUTH NORMANTON, ALFRETON, DE55 2FH, UNITED KINGDOM
1. MEDICINAL PRODUCTS |
1.1 With “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) |
1.2 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in GB or EEA and intended for the UK market |
1.3 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in the UK and not intended for the UK market |
2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS |
2.1 Procurement |
2.2 Holding |
2.3 Supply |
2.4 Export |
2.6 Products imported from countries on a list |
2.6a Products certified under Article 51 of Directive 2001/83/EC |
2.6b Products not certified under Article 51 of Directive 2001/83/EC |
3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS |
3.1.1 Narcotic or psychotropic products |
3.1.2 Medicinal products derived from blood |
3.1.3 Immunological medicinal products |
3.1.4 Radiopharmaceutical (including radionuclide kits) |
3.1.5 Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc) |
3.3 Cold chain products (requiring low temperature handling) |
ALLOGA UK LIMITED, AMBER PARK 7A, UNIT CW72, FARMWELL LANE, SUTTON-IN-ASHFIELD, NG17 1BX, UNITED KINGDOM
1. MEDICINAL PRODUCTS |
1.1 With “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) |
1.2 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in GB or EEA and intended for the UK market |
1.3 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in the UK and not intended for the UK market |
2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS |
2.1 Procurement |
2.2 Holding |
2.3 Supply |
2.4 Export |
2.6 Products imported from countries on a list |
2.6a Products certified under Article 51 of Directive 2001/83/EC |
2.6b Products not certified under Article 51 of Directive 2001/83/EC |
3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS |
3.1.1 Narcotic or psychotropic products |
3.1.2 Medicinal products derived from blood |
3.1.3 Immunological medicinal products |
3.1.4 Radiopharmaceutical (including radionuclide kits) |
ALLOGA UK LIMITED, AMBER PARK 5 AND 6, UNIT C2, FARMWELL LANE, SOUTH NORMANTON, ALFRETON, DE55 2JX, UNITED KINGDOM
1. MEDICINAL PRODUCTS |
1.1 With “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) |
1.2 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in GB or EEA and intended for the UK market |
1.3 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in the UK and not intended for the UK market |
2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS |
2.1 Procurement |
2.2 Holding |
2.3 Supply |
2.4 Export |
2.5 Other ActivitiesThaw labelling of Pfizer and Moderna Covid-19 vaccine |
2.6 Products imported from countries on a list |
2.6a Products certified under Article 51 of Directive 2001/83/EC |
2.6b Products not certified under Article 51 of Directive 2001/83/EC |
3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS |
3.1.1 Narcotic or psychotropic products |
3.1.2 Medicinal products derived from blood |
3.1.3 Immunological medicinal products |
3.1.4 Radiopharmaceutical (including radionuclide kits) |
3.1.5 Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc) |
3.3 Cold chain products (requiring low temperature handling) |
ALLOGA UK LIMITED, UNIT 5, FARMWELL LANE, SUTTON-IN-ASHFIELD, NG17 1BX, UNITED KINGDOM
1. MEDICINAL PRODUCTS |
1.1 With “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) |
1.2 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in GB or EEA and intended for the UK market |
1.3 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in the UK and not intended for the UK market |
2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS |
2.1 Procurement |
2.2 Holding |
2.3 Supply |
2.4 Export |
2.6 Products imported from countries on a list |
2.6a Products certified under Article 51 of Directive 2001/83/EC |
2.6b Products not certified under Article 51 of Directive 2001/83/EC |
3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS |
3.1.1 Narcotic or psychotropic products |
3.1.2 Medicinal products derived from blood |
3.1.3 Immunological medicinal products |
3.1.4 Radiopharmaceutical (including radionuclide kits) |
3.3 Cold chain products (requiring low temperature handling) |
ALLOGA UK LIMITED, AMBER PARK 8, DERBY 370, DERBY COMMERCIAL PARK, RAYNESWAY, DERBY, DE21 7HW, UNITED KINGDOM
1. MEDICINAL PRODUCTS |
1.1 With “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) |
1.2 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in GB or EEA and intended for the UK market |
1.3 Without “an authorisation” (a UK, Great Britain or Northern Ireland Marketing Authorisation, an Article 126a authorisation, a certificate of registration or traditional herbal registration) in the UK and not intended for the UK market |
2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS |
2.1 Procurement |
2.2 Holding |
2.3 Supply |
2.4 Export |
2.6 Products imported from countries on a list |
2.6a Products certified under Article 51 of Directive 2001/83/EC |
2.6b Products not certified under Article 51 of Directive 2001/83/EC |
3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS |
3.1.1 Narcotic or psychotropic products |
3.1.2 Medicinal products derived from blood |
3.1.3 Immunological medicinal products |
3.1.4 Radiopharmaceutical (including radionuclide kits) |